Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRegional Reit Regulatory News (RGL)

Share Price Information for Regional Reit (RGL)

Share Price is delayed by 15 minutes
Get Live Data
88.70    0.30 (0.34%)
Bid:
88.70
Ask:
90.80
Spread: 2.10 (2.368%)
Market Cap: £143.77m
RGL Live PriceLast checked at - London Stock Exchange

Intraday Regional Reit Share Chart

Director/PDMR Shareholding

18 Feb 2016 13:15

RNS Number : 4941P
Regional REIT Limited
18 February 2016
 

Annex DTR3

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

In accordance with the requirements of DTR 3.1.4R, Regional REIT Limited (the "Company") wishes to notify the following changes in the interests in ordinary shares of no par value in the Company

 

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

Regional REIT Limited

DTR 3.1.2 R

3.

Name of persons discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Derek Porter

Ronald Barrie Clapham

Douglas Cumine

Stephen Inglis

Dr Frank Blin

Derek McDonald

 

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest'

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

In respect of the persons in (3) above

Ordinary shares of no par value

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

TCP Founder Partner Limited

Distribution of shares in Regional REIT Limited to each of the individuals in (3) above.

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Derek Porter - 608,320

Ronald Barrie Clapham - 2,999,015

Douglas Cumine - 273,743

Stephen Inglis - 1,502,549

Dr Frank Blin - 304,159

Derek McDonald - 395,407

 

Derek Porter - 0.2%

Ronald Barrie Clapham - 1.1%

Douglas Cumine - 0.09%

Stephen Inglis - 0.5%

Dr Frank Blin - 0.1%

Derek McDonald - 0.1%

 

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

 

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

nil

18 February 2016

 UK

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

HOLDING

 

Derek Porter - 608,320 (0.2%)

Ronald Barrie Clapham - 3,649,600 (1.3%)

Douglas Cumine - 309,378 (0.1%)

Stephen Inglis - 1,502,549 (0.5%)

Dr Frank Blin - 304,159 (0.1%)

Derek McDonald - 395,407 (0.1%)

18 February 2016

 

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which exercisable

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

23.

Any additional information

24.

Name of contact and telephone number for queries

The PDMRs have entered into lock-in agreements in respect of the shares the subject of this notification on substantially the same terms as the lock-in agreement entered into by TCP Founder Partner on IPO

Martin McKay - 020 7845 6100

 

Name of authorised officer of issuer responsible for making notification

 

Martin McKay

Date of notification

18 February 2016

 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFDFDAFMSEFE
Date   Source Headline
19th May 20264:48 pmRNSResult of AGM
19th May 20267:00 amRNSQ1 2026 Trading Update & Dividend Declaration
1st Apr 20267:00 amRNSNotice of AGM
24th Mar 20267:00 amRNSAnnual Financial Report 2025 Full Year Results
20th Mar 202610:10 amRNS-RInvestor Presentation
19th Feb 20267:00 amRNSQ4 2025 Dividend, 2025 Valuation, Trading Update
24th Dec 20257:00 amRNSBanking Facility Refinanced
11th Dec 20257:00 amRNSSimplified Management Arrangements
10th Dec 20257:00 amRNSDisposals Programme Update
27th Nov 20252:02 pmRNSDirector/PDMR Shareholding
25th Nov 202511:07 amRNSDirector/PDMR Shareholding
24th Nov 202510:01 amRNSDirector Declaration
12th Nov 20257:01 amRNSQ3 2025 Trading Update and Dividend Declaration
24th Sep 202512:30 pmRNS-RInvestor Presentation via Investor Meet Company
18th Sep 20257:00 amRNSDisposal of Clearblue Innovation Centre for £8.8m
11th Sep 20253:49 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNS2025 Half Year Results and Dividend Declaration
21st Jul 20259:45 amRNSDirectorate Change
10th Jul 20251:29 pmRNSHolding(s) in Company
7th Jul 20255:02 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSLettings Update
15th May 20252:50 pmRNSResult of AGM
15th May 20257:00 amRNSQ1 2025 Trading Update & Dividend Declaration
1st Apr 20257:00 amRNSNotice of AGM
31st Mar 20255:33 pmRNSHolding(s) in Company (Correction)
25th Mar 20257:00 amRNS2024 Full Year Results
26th Feb 20257:00 amRNSAppointment of Joint Broker
20th Feb 20257:00 amRNSQ4 Dividend, Year End Valuation and Trading Update
20th Jan 20257:00 amRNS-RAnnual Tenant Survey Published
18th Dec 20247:00 amRNSAppointment of Independent NED & Chair Designate
12th Dec 20247:00 amRNSBorrowings Further Reduced
13th Nov 20247:00 amRNSQ3 2024 Trading Update and Dividend Declaration
28th Oct 20247:00 amRNSSolar Panel JV with Sunbird Solar
21st Oct 20244:00 pmRNSDirector Appointment
16th Oct 20244:42 pmRNSHolding(s) in Company
11th Oct 20247:00 amRNSDirectorate Changes
10th Sep 20247:00 amRNS2024 Half Year Results
30th Aug 20247:00 amRNSChange of AIFM
8th Aug 20247:00 amRNSRepayment of Retail Bond
5th Aug 20242:31 pmRNSResult of AGM
5th Aug 20247:00 amRNSAGM Trading Update
1st Aug 202410:11 amRNSTotal Voting Rights
29th Jul 202411:19 amRNSCompletion of Share Consolidation
25th Jul 202411:52 amRNSHolding(s) in Company
24th Jul 20245:59 pmRNSHolding(s) in Company
23rd Jul 20245:17 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:31 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:29 pmRNSDirector/PDMR Shareholding
22nd Jul 20245:11 pmRNSDirector/PDMR Shareholding
22nd Jul 20245:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.